Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05153460 · ClinicalTrials.gov registry record

Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients

A clinical trial, sponsored by Turtle Shell Technologies Pvt..

Terminated
Registry status
10
Enrollment target

NCT05153460: Clinical Trial study, sponsored by Turtle Shell Technologies Pvt..

NCT05153460 is a clinical trial that was terminated before completion, run by Turtle Shell Technologies Pvt.. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05153460 was terminated before completion, sponsored by Turtle Shell Technologies Pvt..

TERMINATED
Registry status
10 participants
Enrollment target

Study Summary

The Dozee VS device developed by Turtle Shell Technologies Pvt. Ltd., is a contactless continuous vital parameters monitoring system. It is designed for continuous and contactless measurement of Heart Rate (HR) and Respiratory Rate (RR). The device uses the concept of ballistocardiography and deploys piezoelectric sensors to capture the micro-vibrations originating from cardiac contractions, upper respiratory tract activity and body movements. This data is then analyzed by a proprietary algorithm and the values of the vital parameters - Heart Rate (HR) and Respiratory Rate (RR) are generated. The captured vital parameters can be accessed remotely via a dashboard which can be accessed on any web browser and a smartphone application. The sensor sheet is placed below the mattress and captures data while the user is resting or sleeping and does not require a sensor to be fixed to the body. It consists of the following sub - units: Contactless sensor sheet, Dozee Pod with power cord, 5 V USB Power Adapter, Health data compute server and Web Dashboard/Mobile App. This provides a more comfortable solution for long-term continuous patient monitoring. Continuous monitoring of people's vital signs, in particular Heart Rate (HR) and Respiratory Rate (RR), may provide a mechanism to alert doctors or nurses of clinical deterioration. Monitoring people's vital signs outside an ICU often relies on nursing staff conducting checks at set intervals. The device can reduce the workload for nursing staff in non-ICU wards.

Primary Outcome

Record heart rate in the investigational device and patient monitor at the same time every 60 seconds. Calculate and compare the root mean square difference (RMSD) per patient and Bland-Alman plot of the heart rate for the investigational device and the gold standard device.

Interventions

  • DEVICE Telemetry and manual monitoring vs Contactless monitoring devices

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-12-09
Est. Completion 2022-04-14
Turtle Shell Technologies Pvt.

4 total trials

Why NCT05153460 stopped before completion

NCT05153460 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Telemetry and manual monitoring vs Contactless monitoring devices is the first listed.

NCT05153460 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05153460 about?

NCT05153460 is a clinical study titled "Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients". The Dozee VS device developed by Turtle Shell Technologies Pvt. Ltd., is a contactless continuous vital parameters monitoring system. It is designed for continuous and contactless measurement of Heart Rate (HR) and Respiratory Rate (RR). The device uses the concept of ballistocardiography and deploy...

What is the current status of trial NCT05153460?

This trial is currently terminated. The enrollment target is 10 participants. The study started on 2021-12-09. Estimated completion is 2022-04-14.

What interventions are being tested in trial NCT05153460?

The interventions under investigation include: Telemetry and manual monitoring vs Contactless monitoring devices (DEVICE).

Who is sponsoring clinical trial NCT05153460?

This trial is sponsored by Turtle Shell Technologies Pvt., which has 4 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05153460, the US trial registry maintained by the National Library of Medicine. NCT05153460 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.